5 results
diagnosis management hematology anemia aplastic carcinogenesis chronic clark cll encephalopathy hemeonc leukemia lymphocytic model neurology posterior pres progression reversible syndrome
Melanoma Pathogenesis Environmental exposure (UV light) + genetic susceptibility (CDKN2A, CDK4, MC1R, BRAF, p16/ARF genes) → accumulation
Melanoma Pathogenesis ... BRAF, p16/ARF genes ... tumour suppressor genes ... #Pathophysiology ... #Oncology #Melanoma
Chronic Lymphocytic Leukemia (CLL) - Summary Overview: • Most common leukemia in adults • Disorder of
CLL) - Summary Overview ... low-risk disease • Indications ... ) • Treatment Agents ... 1) Alkylating agents ... Lymphocytic #Leukemia #oncology
Melanoma tumour progression (based on the Clark model) - Benign melanocytic nevi: controlled proliferation of normal
Melanoma tumour ... continuous atypia (melanoma ... numerous biochemical events ... #Pathophysiology ... #Oncology #Melanoma
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
Aplastic Anemia - Overview ... - Antithyroid medications ... salts • Chemical Agents ... Benzene • Physical Agents ... Aplastic #Anemia #oncology
Posterior Reversible Encephalopathy Syndrome (PRES) Overview Clinico-Radiological Syndrome, characterized by: • Headache • Seizures • Altered mental
Syndrome (PRES) Overview ... Immunosuppressive agents ... Etiology: • Pathophysiology ... Electrolyte abnormality, Medication ... titratable parenteral agents
No results found for "Overview medications pathophysiology comparison agents oncology melanoma"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Overview #medications #pathophysiology #comparison #agents #oncology #melanoma